NCT07828496

Brief Summary

The goal of this clinical trial is to determine whether a Brain-Computer Interface Neurofeedback Training (BCI-NFT) programme can improve cognitive outcomes, and whether electroencephalography (EEG)-based measures can serve as objective markers of cognitive impairment, in children and adolescents aged 7 to 21 years with acquired brain injury (ABI), including traumatic brain injury (TBI), stroke, encephalitis, brain tumour, or epilepsy. A group of children and adolescents aged 7 to 21 years without any history of brain injury or epilepsy will also be enrolled to provide normative EEG data for comparison. The main questions the study aims to answer are:

  • Complete behavioural assessments using the Behavior Assessment System for Children, Third Edition (BASC-3), including parent and/or teacher reports.
  • Complete 12 BCI-NFT sessions over a 10-week period. Each session will last approximately 60 minutes. During each session, participants will wear a wireless EEG headset and interact with neurofeedback computer games designed to respond to their sustained attention, selective attention, and response time.
  • Repeat the BASC-3 behavioural assessments at the end of the study period.
  • Have undergone a recent neuropsychological assessment within the preceding 2 years and ongoing review by a neuropsychologist. Participants in the normative EEG cohort, comprising children and adolescents without a history of brain injury or epilepsy, will attend a single study session. During this session, EEG activity will be recorded both at rest and while participants interact with a three-dimensional (3D) computer game. These recordings will provide normative EEG data against which findings from participants with ABI can be compared.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
21mo left

Started Nov 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress35%
Nov 2025Jun 2028

Study Start

First participant enrolled

November 1, 2025

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

September 3, 2026

Completed
15 days until next milestone

First Posted

Study publicly available on registry

September 18, 2026

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2028

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2028

Last Updated

September 18, 2026

Status Verified

September 1, 2026

Enrollment Period

2.3 years

First QC Date

September 3, 2026

Last Update Submit

September 17, 2026

Conditions

Outcome Measures

Primary Outcomes (5)

  • Change in Attention Threshold

    Change in the game's adaptive attention threshold value, measured at each session, on a normalised scale between 0 to 1, where the greater value indicates greater sustained attention.

    Baseline (Session 1) to final session (Session 12), over 10 weeks

  • Change in Relaxation Threshold

    Change in the game's adaptive threshold value, measured at each session, according to the normalised scale between 0 and 1, where higher value means greater sustained relaxation.

    Baseline (Session 1) to final session (Session 12), over 10 weeks

  • Change in Response Time

    Change in mean response time to in-game stimuli, measured in milliseconds, at each session.

    Baseline (Session 1) to final session (Session 12), over 10 weeks

  • Change in Alpha-Lateralization Index

    Change in the alpha-lateralization index, a unitless measure derived from posterior EEG channels (P7/P8, O1/O2), ranging from -1 to +1, measured at each session.

    Baseline (Session 1) to final session (Session 12), over 10 weeks

  • Change in Beta-to-Alpha Power Ratio

    Change in the ratio of EEG beta-band to alpha-band spectral power, a unitless ratio, measured at each session.

    Baseline (Session 1) to final session (Session 12), over 10 weeks

Secondary Outcomes (2)

  • Internalising problem score on Behavior Assessment System for Children, Third Edition (BASC-3)

    From enrollment to 20 weeks

  • Externalising symptoms score in Behavior Assessment System for Children, Third Edition (BASC-3)

    From enrollment to end of study 20 weeks

Study Arms (2)

BCI

EXPERIMENTAL

Intervention then standard of care

Other: Brain-computer interface with neurofeedback with 3D game sessions

Usual care

EXPERIMENTAL

Usual care followed by intervention

Other: Brain-computer interface with neurofeedback with 3D game sessions

Interventions

12 sessions of BCI-NFT computer games over 10 weeks

Also known as: BCI-NFT
BCIUsual care

Eligibility Criteria

Age7 Years - 21 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Post acquired brain injury (stroke, encephalitis, brain tumour, traumatic brain injury)
  • Epilepsy

You may not qualify if:

  • History of photosensitive seizures
  • Diagnosis of intellectual disability
  • Presence of psychotic symptoms
  • Diagnosis of attention deficit and hyperactivity disorder
  • Diagnosis of autism spectrum disorder
  • Children on methylphenidate
  • Children who are unable to cooperate with neuropsychological assessment of cognitive function

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

KK Women's and Children's Hospital

Singapore, Singapore

RECRUITING

MeSH Terms

Conditions

Epilepsy

Interventions

Brain-Computer InterfacesNeurofeedback

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Electrical Equipment and SuppliesEquipment and SuppliesBiofeedback, PsychologyMind-Body TherapiesComplementary TherapiesTherapeuticsBehavior TherapyPsychotherapyBehavioral Disciplines and ActivitiesFeedback, Psychological

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Assistant Professor

Study Record Dates

First Submitted

September 3, 2026

First Posted

September 18, 2026

Study Start

November 1, 2025

Primary Completion (Estimated)

February 1, 2028

Study Completion (Estimated)

June 30, 2028

Last Updated

September 18, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share

Consent for sharing of individual patient data was not obtained from participants

Locations